Softwr

Research · head to head

Greenphire vs Sapio Sciences

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
Sapio Sciences logo

Sapio Sciences

Research

Science-aware laboratory platform combining LIMS, ELN and scientific data management

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; Sapio Sciences smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade
  • They diverge on capability: Greenphire covers ClinCard, Sapio Sciences covers Unified LIMS and ELN.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and Sapio Sciences actually diverge.

Attributes where Greenphire and Sapio Sciences differ
AttributeGreenphireSapio Sciences
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in Sapio Sciences

  • Unified LIMS and ELN
  • No-code configuration
  • Scientific data management
  • Science-aware data model
  • Analysis tools
  • Regulated support

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot Sapio Sciences
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot Sapio Sciences
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot Sapio Sciences
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot Sapio Sciences

Sapio Sciences

  • Laboratories whose workflows change often enough that vendor change requests become the bottlenecknot Greenphire
  • Biotech organisations needing LIMS and ELN on one data modelnot Greenphire
  • Research groups wanting scientific staff to own configuration rather than ITnot Greenphire
  • Organisations replacing a rigid legacy LIMS they can no longer adaptnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

Sapio Sciences

  • Smaller vendor than the enterprise incumbents, which conservative laboratory procurement weights heavily for a system that must last a decade
  • Pricing is not published, so early comparison requires a sales process
  • No-code configuration still requires someone with the time and inclination to learn it, and laboratories that assign nobody end up where they started
  • Smaller partner ecosystem and fewer independent implementation resources
  • Less accumulated regulatory validation precedent than LabWare, which matters for inspected pharmaceutical QC

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

Sapio Sciences

On request
  • Sapio Platform$undefined/year
    • LIMS
    • ELN
    • Scientific data management

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose Sapio Sciences if

  • You need unified lims and eln.
  • You work on Web, Cloud, On-premise.
  • You also want no-code configuration.
Sapio Sciences review

Questions people ask

Is Greenphire or Sapio Sciences better?
Neither clearly leads. Greenphire starts at On request and Sapio Sciences at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or Sapio Sciences?
Greenphire starts at On request and Sapio Sciences at On request.
Does Greenphire or Sapio Sciences run on more platforms?
Greenphire runs on Web, iOS, Android. Sapio Sciences runs on Web, Cloud, On-premise.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what Sapio Sciences is typically brought in for.
What can Greenphire do that Sapio Sciences cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. Sapio Sciences covers Unified LIMS and ELN, No-code configuration, Scientific data management, Science-aware data model.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

Sapio Sciences: What is the no-code claim actually about?

Changing workflows, data models and screens without a vendor services engagement. The problem it targets is real: most LIMS are configured once at implementation and every later change becomes a costly change request.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

Sapio Sciences: Does no-code mean no effort?

No. Someone in the laboratory has to learn the configuration model and own it. Laboratories that assign nobody end up with the same rigidity they were escaping.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

Sapio Sciences: What does it cost?

Not published. Annual enterprise licensing quoted on users and modules.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

Sapio Sciences: Is it suitable for regulated QC?

It supports regulated environments, but LabWare and STARLIMS have far more accumulated validation precedent. For inspected pharmaceutical QC that history carries real weight.

Sapio Sciences: How does it compare to Benchling?

Both are modern and science-aware. Benchling is stronger in research molecular biology; Sapio positions more toward configurable LIMS and ELN across research and regulated work.

Share

Related pages

More on Greenphire

More on Sapio Sciences

Keep looking

Other head to heads